Regeneron Pharmaceuticals Inc
LSE:0R2M
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of
Regeneron Pharmaceuticals Inc (0R2M) under the Base Case is USD per share.
Compared with the current market price of 924.8081 USD, the stock appears .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
What one share is worth in the bear, base and bull cases.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Intrinsic value next to the price over the past 12 months.
Create a free account · No card needed
Fundamental Analysis
What Regeneron Pharmaceuticals Does
Regeneron Pharmaceuticals makes prescription medicines, mostly biologic drugs that are built from antibodies and other protein-based therapies. It develops treatments for eye diseases, allergies, inflammation, cancer, and rare genetic disorders, then sells them through hospitals, clinics, pharmacies, and specialty distributors. Its main customers are patients and the doctors and health systems that treat them, along with insurers and government health programs that pay for the drugs.
- Headquarters
- United States of America US
- Employees
- 15 410
- IPO date
- Apr 2, 1991
Regeneron Pharmaceuticals has a narrow economic moat
Legal protection for medicines such as Dupixent and EYLEA HD prevents rivals from freely copying them, helping Regeneron preserve sales and profits. This protection covers specific medicines rather than whole treatment markets, where competing drugs remain available.
Read the full moat analysisBalance Sheet
Recent Events
Latest Earnings Call
Record-setting brands and a broad pipeline define the quarter, while an expanded Sanofi alliance advances long-acting type 2 inflammation medicines.
Open the earnings call- EPS
- $18.43
- Expected
- $13.76
- Surprise
- +33.9%
- Stock, day of the call
- +13.3%
Regeneron Pharmaceuticals insiders are selling within their usual range
Past 12 months
Continue 0R2M Research
Decided on Regeneron Pharmaceuticals? Get an email when 0R2M reaches the price you’d buy at. Free with an account.
Other Regeneron Pharmaceuticals listings
What is the Intrinsic Value of one 0R2M stock?
The intrinsic value for
Regeneron Pharmaceuticals Inc (0R2M) under the Base Case is USD.
Is 0R2M stock undervalued or overvalued?
Compared with the current market price of 924.8081 USD, the stock appears .